Select Medical (SEM) Raised to “Neutral” at Bank of America

Bank of America upgraded shares of Select Medical (NYSE:SEM) from an underperform rating to a neutral rating in a research note released on Thursday, MarketBeat Ratings reports. They currently have $19.00 price target on the health services provider’s stock.

A number of other analysts also recently issued reports on SEM. Royal Bank of Canada reaffirmed a buy rating and set a $19.00 price target on shares of Select Medical in a report on Wednesday, September 13th. ValuEngine downgraded Select Medical from a buy rating to a hold rating in a report on Monday, October 2nd. Zacks Investment Research downgraded Select Medical from a buy rating to a hold rating in a report on Tuesday, October 10th. Robert W. Baird reaffirmed a buy rating and set a $21.00 price target on shares of Select Medical in a report on Tuesday, October 17th. Finally, Deutsche Bank reaffirmed a buy rating and set a $22.00 price target on shares of Select Medical in a report on Monday, November 6th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and five have given a buy rating to the stock. The stock has an average rating of Hold and an average price target of $19.43.

Shares of Select Medical (SEM) traded up $0.25 during midday trading on Thursday, reaching $18.00. The company’s stock had a trading volume of 729,870 shares, compared to its average volume of 723,170. The stock has a market cap of $2,410.00, a P/E ratio of 25.00, a price-to-earnings-growth ratio of 1.18 and a beta of 1.34. The company has a debt-to-equity ratio of 3.36, a current ratio of 1.51 and a quick ratio of 1.51. Select Medical has a 12 month low of $12.00 and a 12 month high of $19.77.

Select Medical (NYSE:SEM) last announced its quarterly earnings results on Thursday, November 2nd. The health services provider reported $0.14 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.16 by ($0.02). The business had revenue of $1.10 billion for the quarter, compared to analysts’ expectations of $1.10 billion. Select Medical had a return on equity of 11.44% and a net margin of 2.21%. The firm’s quarterly revenue was up 4.1% on a year-over-year basis. During the same period last year, the firm earned $0.06 earnings per share. equities analysts anticipate that Select Medical will post 0.86 earnings per share for the current year.

In other news, insider Martin F. Jackson sold 134,029 shares of the business’s stock in a transaction dated Friday, December 22nd. The stock was sold at an average price of $17.05, for a total value of $2,285,194.45. Following the completion of the sale, the insider now directly owns 1,717,944 shares of the company’s stock, valued at approximately $29,290,945.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Scott A. Romberger sold 5,000 shares of the business’s stock in a transaction dated Wednesday, November 29th. The shares were sold at an average price of $17.97, for a total value of $89,850.00. Following the completion of the sale, the insider now directly owns 168,211 shares of the company’s stock, valued at $3,022,751.67. The disclosure for this sale can be found here. Insiders sold a total of 314,455 shares of company stock valued at $5,403,144 over the last three months. Company insiders own 19.93% of the company’s stock.

Institutional investors and hedge funds have recently bought and sold shares of the business. Pacad Investment Ltd. raised its stake in Select Medical by 58.7% during the 2nd quarter. Pacad Investment Ltd. now owns 7,300 shares of the health services provider’s stock valued at $112,000 after acquiring an additional 2,700 shares during the last quarter. PNC Financial Services Group Inc. raised its stake in Select Medical by 4.8% during the 2nd quarter. PNC Financial Services Group Inc. now owns 8,709 shares of the health services provider’s stock valued at $133,000 after acquiring an additional 396 shares during the last quarter. Riverhead Capital Management LLC raised its stake in Select Medical by 78.0% during the 2nd quarter. Riverhead Capital Management LLC now owns 8,722 shares of the health services provider’s stock valued at $134,000 after acquiring an additional 3,822 shares during the last quarter. Flinton Capital Management LLC raised its stake in Select Medical by 75.8% during the 2nd quarter. Flinton Capital Management LLC now owns 9,744 shares of the health services provider’s stock valued at $150,000 after acquiring an additional 4,200 shares during the last quarter. Finally, Shelton Capital Management purchased a new stake in Select Medical during the 2nd quarter valued at approximately $164,000. 77.89% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: “Select Medical (SEM) Raised to “Neutral” at Bank of America” was published by Community Financial News and is the property of of Community Financial News. If you are viewing this article on another site, it was illegally copied and reposted in violation of international trademark and copyright law. The legal version of this article can be accessed at https://www.com-unik.info/2018/01/07/select-medical-sem-raised-to-neutral-at-bank-of-america.html.

About Select Medical

Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.

Analyst Recommendations for Select Medical (NYSE:SEM)

What are top analysts saying about Select Medical? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Select Medical and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit